The cost-effectiveness of β-radiation therapy for treatment of in-stent restenosis: An analysis at 290-day follow-up

Cardiovascular Radiation Medicine

Volumn 3, Issue 2, 2002, Pages 107-113

  Beusterien, Kathleen M ^a   Plante, Kathryn M ^a   Waksman, Ron ^b   Raizner, Albert E ^c   Annis, Marijke ^d   Goss, Thomas F ^a  

^a Health Economics and Outcomes Research   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c HOUSTON METHODIST HOSPITAL   (United States)

^d BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

Coronary artery disease; Coronary restenosis; Coronary revascularization; Coronary stent; Cost effectiveness; INHIBIT trial; Percutaneous coronary intervention; Radiotherapy; radiation

Indexed keywords

ADULT; AGED; ARTICLE; BETA RADIATION; CONTROLLED STUDY; CORONARY STENT; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; MEDICARE; PRIORITY JOURNAL; RESTENOSIS; UNITED STATES;

EID: 0036556953     PISSN: 15221865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1522-1865(02)00157-9     Document Type: Article

References (23)

1. 1998 Heart and stroke statistical update. 1997;American Heart Association, Dallas (TX).
2. Cleland J.G.F. Can improved quality of care reduce the costs of managing angina pectoris? Eur Heart J. 17(Suppl A):1996;29-40.
3. Ghandi M.M., Lampe F., Wood D.A. Incidence of stable angina pectoris. Eur Heart J. 13:1992;181.
4. Cannon P.J., Connell P.A., Stockley I.H., Garner S.T., Hampton J.R. Prevalence of angina as assessed by a survey of prescriptions for nitrates. Lancet. 1:1988;979-981.
5. Kimmel S.E., Localio R., Brensinger C., Miles C., Hirshfeld J., Haber H.L., Strom B.L. Effects of coronary stents on cardiovascular outcomes in broad-based clinical practice. Arch Intern Med. 160:2000;2593-2599.
6. Moussavian M., Casterella P.J., Teirstein P.S. Restenosis after angioplasty. Curr Treatm Opt Cardiovasc Med. 3:2001;103-112.
7. Teirstein P.S., Massullo V., Jani S., Popma J.J., Mintz G.S., Russo R.J., Schatz R.A., Guarneri E.M., Steuterman S., Morris N.B., Leon M.B., Tripuraneni P. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med. 336:1997;1697-1703.
8. Latchem D.R., Urban P., Goy J.J., De Benedetti E., Pica A., Coucke P., Eeckhout E. Beta-radiation for coronary in-stent restenosis. Catheter Cardiovasc Interv. 51:2000;422-429.
9. Raizner A.E., Oesterle S.N., Waksman R., Serruys P.W., Colombo A., Lim Y.L., Yeung A.C., van der Giessen W.J., Vandertic L., Chiu J.K., White L.R., Fitzgerald P.J., Kaluza G.L., Ali N.M. Inhibition of restenosis with beta-emitting radiotherapy. Circulation. 102:2000;951-958.
10. Waksman R., Raizner A.E., Yeung A.C., Lansky A.J., Vandertie L. Use of localised intracoronary radiation in the treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet. 359:2002;551-557.
11. Hsiao W.C., Braun P., Dunn D., Becker E.R. Resource-based relative values: an overview. JAMA. 260:1988;2347-2353.
12. Diagnosis Related Groups Definitions Manual, Version 180. Washington (DC): 3M Health Information Systems. Document number: 00-034 Rev. 00.
13. Current Procedural Terminology 2001. 2001;American Medical Association, Chicago (IL).
14. Federal Register, Nov. 1, 2000; 65(212); Washington (DC): United States Government Printing Office.
15. Federal Register, Nov. 13, 2000; 65(219); Washington (DC): United States Government Printing Office.
16. Seto T.B., Cohen D.J. Cost-effectiveness of adjunctive intracoronary brachytherapy for the treatment of in-stent restenosis. Vasc Radiother Monit. 4(1):2001;9-15.
17. Cohen D.J., Krumholz H.M., Sukin C.A., Ho K.K.L., Siegrist R.B., Cleman M., Heuser R.R., Brinker J.A., Moses J.W., Savage M.P., Detre K., Leon M.B., Baim D.S. In-hospital and one-year outcomes after coronary stenting or balloon angioplasty. Circulation. 92:1995;2480-2487.
18. 2001 Drug topics redbook. 2001;Medical Economics, Montvale (NJ).
19. Medicaid pharmacy-actual acquisition cost of brand name prescription drug products, Department of Health and Human Services, Office of Inspector General, August 2001.
20. Gardiner J., Hogan A., Holmes-Rovner M., Rovner D., Griffith L., Kupersmith J. Confidence intervals for cost-effectiveness ratios. Med Decis Mak. 15:1995;254-263.
21. Mooney C.Z., Duval R.D. Bootstrapping: a nonparametric approach to statistical inference. 1993;Sage Publications, Newbury Park.
22. Cohen D.J., Leon M.B., Teirstein P., Cosgrove R., Jones M.A., Berezin R.H., Ho K.K., Cutlip D.E., Kuntz R.E. Economic assessment of gamma-brachytherapy for treatment of in-stent restenosis: results from the randomized GAMMA-1 trial. J Am Coll Cardiol. 35(2):2000;32. Suppl A.
23. Weintraub W.S., Mauldin P.D., Becker E., Kosinski A.S., King S.B. A comparison of the costs of and quality of life after coronary angioplasty for coronary surgery for multivessel coronary artery disease. Circulation. 92:1995;2831-2840.